Updates are available Correction dated 2020-08-31
Click to view Correction: https://doi.org/10.1038/s41541-020-00230-2
-
Authors
Harrison, Nicole
Grabmeier-Pfistershammer, Katharina
Graf, Alexandra
Schwarzinger, Ilse
Aberle, Judith H.
Stiasny, Karin http://orcid.org/0000-0002-1902-8674
Greinix, Hildegard
Rabitsch, Werner
Kalhs, Peter
Ramharter, Michael
Burgmann, Heinz
Forstner, Christina http://orcid.org/0000-0002-4427-2839
-
Funding
Funding for this research was provided by:
Austrian Science Fund (KLI 372) Pfizer sponsored TBE vaccines and Neutralization assays
- License Information
-
More Information
Article History
Received: 9 April 2020
Accepted: 3 July 2020
First Online: 24 July 2020
Change Date: 12 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-020-00230-2
Competing interests
: C.F. received a grant of the Austrian Science Fund (grant number KLI 372) that enabled to conduct the present study and partly supported employment of N.H. H.B. received a research grant from Pfizer (Project No. WI201689), who performed neutralization assays and supplied TBE vaccines free of cost. Pfizer had no role in the conceptualization, design of the study or the decision to publish. All other authors report no competing interests related to the present work.
